Release Date: 05/02/24 09:12 Summary: SUPPLEMENTARY PRODUCT DISCLOSURE STATEMENT NO. 3 Price Sensitive: No Download Document 2MB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status